Comparative Analysis of Serum Lipid Profiles Among Hypertensive and Diabetic Patients in Kaduna State, Northwest,Nigeria: A Retrospective Study
Keywords:
Comparative, Diabetes, Dyslipidaemia, Hypertension, HDL, LDL, Lipid profileAbstract
The serum lipid profile is a key biochemical parameter that serves as a marker for predicting adverse cardiovascular events. This study aims to analyze and compare the serum lipid profiles among hypertensive and diabetic patients. The serum lipid profiles of 172 hypertensive and 142 diabetic patients, seen over a four-year period (2019 – 2022), were retrieved from the electronic database of the Department of Chemical Pathology and Immunology, at Barau Dikko Teaching Hospital, Kaduna. The percentages of patients with abnormal lipid values were calculated for various lipids in both groups. T-test was used to compare the mean lipid values between the two groups. Among hypertensive patients, the percentages of abnormal lipid values were as follows: HDL (16.0%), LDL (25.6%), total cholesterol (31.8%), and triglycerides (14.0%), with 5.8% having both elevated cholesterol and triglycerides. In the diabetic group, the percentages were: HDL (22.4%), LDL (16.9%), total cholesterol (30.1%), and triglycerides (13.8%), with 7.3% having both elevated total cholesterol and triglycerides. The mean lipid values for hypertensive versus diabetic patients were compared as follows: HDL (1.3±0.8 vs 1.2±0.3, t=1.737, p=0.08), LDL (3.3±1.0 vs 3.1±1.1, t=2.170, p=0.03), total cholesterol (5.3±1.2 vs 5.2±1.7, t=0.598, p=0.55), and triglycerides (1.6±1.0 vs 1.6±0.6, t=0.389, p=0.70).The predominant lipid abnormality among both hypertensive and diabetic patients was hypercholesterolaemia. Hypertensive patients had significantly higher LDL levels compared to diabetic patients.
References
1. World Health Organization. Cardiovascular diseases (CVDs) Fact Sheets. [cited 2025 Oct 19]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 19/10/2025
2. Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016 May;26(4):364–73.
3. Afolabi HA, Ojurongbe TA, Ayelagbe OG, Akinleye C, Ogunniran MO, Bashiru KA, et al. Influence of Lipid Profiles on Type 2 Diabetes Risk in Nigerian Patients. In Review; 2024 [cited 2025 Oct 19]. Available from: https://www.researchsquare.com/article/rs-5267986/v1
4. Akintunde AA, Ayodele EO, Akinwusi OP, Opadijo GO. dyslipidaemia among newly diagnosed hypertensives: pattern and clinical correlates. J Natl Med Assoc. 2010 May;102(5):403–7.
5. IBM. SPSS Statistical Software for Windows. [Internet]. Armonk, New York, USA: IBM; 2010. Available from: https://www.ibm.com/products/software
6. Adetola A, Abodunde G, Matthew JI, Ani I. Prevalence of obesity, hypertension, and diabetes among patients attending outpatient clinic at a tertiary health institution in Southwestern Nigeria. Niger J Cardiol. 2021 Jan 1;18.
7. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016 Oct 14;37(39):2999–3058.
8. Aryee C, Owiredu WKBA, Osei-Yeboah J, Owusu-Dabo E, Laing EF, Owusu IK. An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy. Int J Hypertens. 2016;2016:1–14.
9. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–8.
10. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 June 24;129(25 Suppl 2):S1-45.
11. Cole Kennelly. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes. In American Diabetes Association; 2020. p. Suppl.1 (S111-S134).
